MAKOWER JOSHUA

Average Profitability
<0.0001%
Insider Buys Quantity
10
Insider Buys Sum
$147.08M
Insider Sells Quantity
1
Insider Sells Sum
$3,000.48

Insider Activity of MAKOWER JOSHUA

The largest purchase of all time was on 2019-05-09 and amounted to 5000000 shares of Trevi Therapeutics, Inc. for $35M.

The largest sale of all time was on 2020-04-03 and amounted to 1128 shares of Trevi Therapeutics, Inc. for $3,000.

Biography of MAKOWER JOSHUA

No biography is available at this moment.

2021-06-28PurchaseMonte Rosa Therapeutics, Inc.
GLUE
10 percent owner
1.05M
20.5778%
$19.00$19.95M-7.95%
2021-03-16PurchaseMarker Therapeutics, Inc.
MRKR
10 percent owner
5.71M
9.5207%
$1.75$10M-4.3%
2020-12-04PurchaseRegulus Therapeutics Inc.
RGLS
10 percent owner
4.4M
7.578%
$0.62$2.74M+22.37%
2020-07-28PurchaseInozyme Pharma, Inc.
INZY
10 percent owner
500,000
1.2168%
$8.00$4M+19.03%
2020-07-14PurchaseNkarta, Inc.
NKTX
10 percent owner
1.33M
2.1488%
$18.00$24M-11.28%
2020-04-03SaleTrevi Therapeutics, Inc.
TRVI
10 percent owner
1,128
0.0062%
$2.66$3,000+19.07%
2019-07-22PurchaseMirum Pharmaceuticals, Inc.
MIRM
10 percent owner
900,000
5.3814%
$15.00$13.5M+5.09%
2019-05-09PurchaseTrevi Therapeutics, Inc.
TRVI
10 percent owner
5M
24.2282%
$7.00$35M-42.9%
2019-05-07PurchaseRegulus Therapeutics Inc.
RGLS
10 percent owner
1.14M
6.1239%
$1.08$1.23M-40%
2016-07-18PurchaseArdelyx, Inc.
ARDX
10 percent owner
3.05M
5.9523%
$8.73$26.67M+25.38%
2016-01-13PurchaseArdelyx, Inc.
ARDX
10 percent owner
1M
3.0335%
$10.00$10M+4.47%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.